Journal of Infectious Diseases & Preventive Medicine
Open Access

Department of Clinical Laboratory Services, Institute of Human Virology, Abuja, Nigeria

Biography

Dr. Abbas Abel Anzaku is in Clinical laboratory and research scientist with six (6) years of experience in the diagnosis of infectious diseases; experienced in immunoassay. Peripheral Blood Mononuclear Cells (PBMCs) from over 2000 whole blood samples for a research project that focus on non-communicable diseases amongst HIV and non-HIV infected individuals, collaborative research with the University of Maryland, Baltimore, and the United States of America. Area of interest includes HIV, infection prevention control, Viral Hepatitis, Tuberculosis, and other infectious diseases of public health importance.

Publications

• Review Article   
  Epidemiology, Viral Pathogenesis, Host-Immune Response and PotentialVaccine Trial for the Treatment of SARS-CoV-2 Infection
  Author(s): Abbas Abel Anzaku*, Olasinbo Balogun, Akwashiki Ombugadu, Nneka Egbuchulam, Ibrahim Yusuf, Ifeanyichuku Odoh, Nurudeen Olalekan Oketade and Akpason Esla Amre
  
  Background: The current outbreak of COVID-19 caused by SARS-CoV-2 raised fundamental public health concerns as its emergence has been marked the third introduction of a highly pathogenic coronavirus into the human population after SARS-CoV and MERS-CoV in the twenty-first century. Recent advancement of SARS-CoV-2 infection revealed mechanism of immune evasion during the pathogenesis. Hence, this study reviewed available literature on epidemiology of SARS-CoV-2, viral pathogenesis, host immune response to the infection and potential vaccine trial for the treatment of the infection. Methods: Systematic review technique was used for this study. Results: This study provides an immunological insight i nto the SARS-CoV-2 infection for better understating of the virus and as well as the strategies for use in.. View More»
  DOI: 10.35248/2329-8731.20.8.209

  Abstract HTML PDF